Patent · US Active

Method for treatment of heart failure

US10059946B2 · kind B2 · utility

0Cited by

0References

1Claims

0Family size

Assignee

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Frederic Jaisser · Paris, FR
Nicolette Farman · Paris, FR

Key dates

Filing date	Aug 29, 2016
Grant date	Aug 28, 2018
Priority date	—
Expiry date	Aug 29, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an inhibitor of NGAL gene expression or a NGAL antagonist for use in the prevention or the treatment of heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.